Inactivated vaccine-elicited potent antibodies can broadly neutralize SARS-CoV-2 circulating variants
Description
A full understanding of the inactivated COVID-19 vaccine-mediated antibody responses to SARS-CoV-2 circulating variants will inform vaccine effectiveness and vaccination development strategies. Here, we offer insights into the inactivated vaccine
